谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Randomized Phase III GnG Study on Two Schedules of Gemtuzumab Ozogamicin As Adjunct to Intensive Induction Therapy and Double-Blinded Intensive Postremission Therapy with or Without Glasdegib in Patients with Newly Diagnosed Acute Myeloid Leukemia.

Sonia Jaramillo,Johannes Krisam,Lucian Le Cornet,Markus Kratzmann,Lukas Baumann, Olga Eissymont,Martina Crysandt,Martin Goerner,Sabine Kayser,Stefan Krause,Christoph Schliemann,Tobias Gaska,Martin Kaufmann,Jens Chemnitz,Markus Schaich,Alexander Hoellein,Uwe Platzbecker,Meinhard Kieser,Carsten Mueller-Tidow,Richard F. Schlenk

Haematologica（2024）

引用 0|浏览33
关键词
International Myeloma Working Group
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要